TSG Research Evaluates Opportunities for Future Growth & Expansion in Point of Care Diagnostics
Point of Care (POC) diagnostics, a $11.3 billion market growing at 10-12% annually, has been featured in a new report by leading life sciences advisory firm TSG. This report highlights 7 key drivers in this emerging category, along with high-growth subcategories and a market snapshot of 34 leading POC companies.
Atlanta, GA, April 07, 2009 --(PR.com)-- A newly-released report from TSG, a leading global advisory firm focusing on the life sciences and health and wellness sectors, provides key insights into the future of the $11.3 billion point of care (POC) diagnostics market.
With growth accelerating to more than 11% annually, POC testing provides highly actionable, near-patient diagnostic information that is driving an increasing proportion of the global healthcare spend. TSG's conversations with leading diagnostic experts have revealed the seven key drivers of growth in this emerging category, which include consumer empowerment, the rise of higher-value testing, and a growing focus on personalized medicine initiatives.
The report also contains TSG's POC Dx Leaderboard™, a market snapshot detailing the competitive strengths and weaknesses of more than thirty leading private and public POC companies. In addition, TSG has identified several high-growth subcategories of interest to companies looking to expand their portfolios in point of care, and highlighted key competitive developments and trends in the category from both a technology and market perspective.
TSG's report closes with a discussion of four scenarios which could impact the future of POC market. Although the POC sector is currently highly fragmented, POC companies will need to carefully consider how to protect their existing business in each of these scenarios as the sector becomes increasingly consolidated through both inter-sector and cross-sector M&A activity.
Individuals interested in learning more can download the research on TSG's homepage, www.tsg-partners.com, where they can also register to receive TSG's market updates, which feature market commentary and key developments across TSG's ten proprietary indices in the life sciences and nutrasciences. TSG's coverage across the life sciences includes indices for Point of Care, Molecular Diagnostics, Global Diagnostics, Lab Services, and Drug Discovery / BioTools.
About TSG
TSG (www.tsg-partners.com) is a specialty advisory group that combines growth strategy and corporate finance to create shareholder value for companies in the life sciences, biotechnology, healthcare, and wellness sectors. TSG’s approach is based on a combination of independent analysis of the markets and customer needs and a deep appreciation of the technology landscape and capital markets environment. TSG’s sole focus is on bringing together growth strategy and transaction insight to build sector leaders in life sciences. TSG has presence in Atlanta, Boston, New York and Silicon Valley and was founded in 2001 by Panna Sharma. TSG can be found on the internet at www.tsg-partners.com.
###
With growth accelerating to more than 11% annually, POC testing provides highly actionable, near-patient diagnostic information that is driving an increasing proportion of the global healthcare spend. TSG's conversations with leading diagnostic experts have revealed the seven key drivers of growth in this emerging category, which include consumer empowerment, the rise of higher-value testing, and a growing focus on personalized medicine initiatives.
The report also contains TSG's POC Dx Leaderboard™, a market snapshot detailing the competitive strengths and weaknesses of more than thirty leading private and public POC companies. In addition, TSG has identified several high-growth subcategories of interest to companies looking to expand their portfolios in point of care, and highlighted key competitive developments and trends in the category from both a technology and market perspective.
TSG's report closes with a discussion of four scenarios which could impact the future of POC market. Although the POC sector is currently highly fragmented, POC companies will need to carefully consider how to protect their existing business in each of these scenarios as the sector becomes increasingly consolidated through both inter-sector and cross-sector M&A activity.
Individuals interested in learning more can download the research on TSG's homepage, www.tsg-partners.com, where they can also register to receive TSG's market updates, which feature market commentary and key developments across TSG's ten proprietary indices in the life sciences and nutrasciences. TSG's coverage across the life sciences includes indices for Point of Care, Molecular Diagnostics, Global Diagnostics, Lab Services, and Drug Discovery / BioTools.
About TSG
TSG (www.tsg-partners.com) is a specialty advisory group that combines growth strategy and corporate finance to create shareholder value for companies in the life sciences, biotechnology, healthcare, and wellness sectors. TSG’s approach is based on a combination of independent analysis of the markets and customer needs and a deep appreciation of the technology landscape and capital markets environment. TSG’s sole focus is on bringing together growth strategy and transaction insight to build sector leaders in life sciences. TSG has presence in Atlanta, Boston, New York and Silicon Valley and was founded in 2001 by Panna Sharma. TSG can be found on the internet at www.tsg-partners.com.
###
Contact
TSG
Laura White
1-404-607-6954
www.tsg-partners.com
Laura White
1-404-607-6954
www.tsg-partners.com
Contact
Categories